
Spring, male hormones and health: what you need to know
04.03.2025

A delegation from the Cuban Ministry of Health visited Belarus to launch cooperation in the pharmaceutical sector
04.03.2025

10 years we take care of the main thing. Presentation film
24.10.2022

We take care of the main thing. Presentation film
24.10.2022

Рresentation film 2018
24.10.2022

Rivaksan has become more affordable
20.12.2021

Rivaksan-Innovation of the Year at the 2021 Eurasian Summit
15.10.2021
On December 19, 2019, the shipment of the NEW antihypertensive drug NEBIVOLO-NAN, manufactured by the State Enterprise “ACADEMPHARM”, began. Nebivolol-NAN is a highly selective third-generation Beta1-adrenergic blocker that provides an additional vasodilator effect by modulating the release of an endothelium-dependent relaxing factor for the treatment of arterial hypertension and heart failure.
INN: Nebivolol
Dosage and packing: 5 mg No. 30
The main characteristics of the new drug:
- Improves the quality of life of patients with hypertension
- Well tolerated
- Does not reduce physical performance
- Does not affect sexual performance